Literature DB >> 25652434

Expression of interleukin-9 and its upstream stimulating factors in rats with ischemic stroke.

Yinyao Lin1, Lei Zhang, Yongqiang Dai, Haiyan Li, Yanqiang Wang, Bingjun Zhang, Suqin Chen, Zhengqi Lu.   

Abstract

To investigate the temporal expressions of IL-9 and its related cytokines after middle cerebral artery occlusion in rats. IL-9 and its related cytokines in ischemia brain and blood were tested after rats were subjected to transient focal ischemia. Comparing with sham-operated group, the levels of IL-4, TGF-β, PU.1, IRF4, OX40, NIK, RelB-p52 and IL-9 in experimental groups were significantly higher after middle cerebral artery occlusion. The results showed that expressions of IL-9 and its upstream stimulating factors increased in experimental stroke, and whether they play a role or just a secondary change is awaiting further research.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25652434     DOI： 10.1007/s10072-015-2096-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  27 in total

1.  Infarct measurement methodology.

Authors:  R A Swanson; F R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  1994-07       Impact factor: 6.200

2.  Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury.

Authors:  F C Barone; B Arvin; R F White; A Miller; C L Webb; R N Willette; P G Lysko; G Z Feuerstein
Journal:  Stroke       Date:  1997-06       Impact factor: 7.914

Review 3.  Stroke and stroke care in China: huge burden, significant workload, and a national priority.

Authors:  Liping Liu; David Wang; K S Lawrence Wong; Yongjun Wang
Journal:  Stroke       Date:  2011-11-03       Impact factor: 7.914

4.  Regulating Il9 transcription in T helper cells.

Authors:  Narayanan B Perumal; Mark H Kaplan
Journal:  Trends Immunol       Date:  2011-03-02       Impact factor: 16.687

5.  Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes.

Authors:  Veit J Erpenbeck; Jens M Hohlfeld; Brunhild Volkmann; Andreas Hagenberg; Henning Geldmacher; Armin Braun; Norbert Krug
Journal:  J Allergy Clin Immunol       Date:  2003-06       Impact factor: 10.793

6.  Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.

Authors:  Teng Guan; Qian Liu; Yisong Qian; Haopeng Yang; Jiming Kong; Junping Kou; Boyang Yu
Journal:  Eur J Pharmacol       Date:  2013-07-30       Impact factor: 4.432

7.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

8.  Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain.

Authors:  G Y Yang; C Gong; Z Qin; W Ye; Y Mao; A L Bertz
Journal:  Neuroreport       Date:  1998-06-22       Impact factor: 1.837

9.  The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.

Authors:  Hua-Chen Chang; Sarita Sehra; Ritobrata Goswami; Weiguo Yao; Qing Yu; Gretta L Stritesky; Rukhsana Jabeen; Carl McKinley; Ayele-Nati Ahyi; Ling Han; Evelyn T Nguyen; Michael J Robertson; Narayanan B Perumal; Robert S Tepper; Stephen L Nutt; Mark H Kaplan
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

10.  Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume.

Authors:  Heidi Ormstad; Hans Christian Dalsbotten Aass; Niels Lund-Sørensen; Karl-Friedrich Amthor; Leif Sandvik
Journal:  J Neurol       Date:  2011-03-20       Impact factor: 4.849
View more
  3 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

Review 2.  Interleukins and Ischemic Stroke.

Authors:  Hua Zhu; Siping Hu; Yuntao Li; Yao Sun; Xiaoxing Xiong; Xinyao Hu; Junjing Chen; Sheng Qiu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

3.  High serum OX40 ligand correlates with severity and mortality in patients with massive cerebral infarction.

Authors:  Lun-Lin Mao; Wen-Ya Chen; Ai-Jin Ma; Li-Li Ji; Ting-Ting Huang
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.